SAN FRANCISCO, Jan. 3, 2017 /PRNewswire/ -- Symic Bio, a clinical stage biopharmaceutical company focused on matrix biology developing a new category of therapeutics, today announced that Ken Horne, Chief Executive Officer, will participate in the 2017 East/West CEO Conference on a panel entitled "Global Perspectives on Funding and Innovation."
Conference details are as follows:
Date: Sunday, Jan. 8, 2017
Time: 7:40 a.m. PST
Location: Four Seasons Hotel, San Francisco